The stock of Aralez Pharmaceuticals Inc (NASDAQ:ARLZ) is a huge mover today! About 367,988 shares traded hands. Aralez Pharmaceuticals Inc (NASDAQ:ARLZ) has risen 38.36% since April 14, 2016 and is uptrending. It has outperformed by 33.67% the S&P500.
The move comes after 9 months positive chart setup for the $330.41M company. It was reported on Nov, 16 by Barchart.com. We have $13.68 PT which if reached, will make NASDAQ:ARLZ worth $502.22M more.
According to Zacks Investment Research, “Aralez Pharmaceuticals Inc. is a global specialty pharmaceutical company. They acquire, develop and commercialize products primarily in cardiovascular, pain and other specialty areas.”
More notable recent Aralez Pharmaceuticals Inc (NASDAQ:ARLZ) news were published by: Seekingalpha.com which released: “Pleasant Surprises Ahead For Aralez Pharmaceuticals’ Shareholders” on November 14, 2016, also Seekingalpha.com with their article: “CEO Adrian Adams Is Prepping Aralez For A Sale” published on November 15, 2016, Fool.com published: “Why Aralez Pharmaceuticals Inc Jumped Higher Today” on August 01, 2016. More interesting news about Aralez Pharmaceuticals Inc (NASDAQ:ARLZ) were released by: Fool.com and their article: “Why Aralez Pharmaceuticals Inc. Approved a Higher Price Today” published on September 15, 2016 as well as Marketwatch.com‘s news article titled: “/quotes/zigman/3870025/realtime” with publication date: February 12, 2016.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.